Sebastian Krug

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Marko Damm

University Hospital Halle (Saale)

GERMANY

View details

Ulrich Ronellenfitsch

Associate Professor of Surgery

GERMANY

View details

Florian van Bömmel

Professor of Medicine

University Hospital Leipzig

GERMANY

View details

Jörg Kleeff

GERMANY

View details

Jens Walldorf

Martin Luther University Halle-Wittenberg

GERMANY

View details

Maria A. Gonzalez‐Carmona

GERMANY

View details

Marino Venerito

GERMANY

View details

Jörg Ukkat

University Hospital Halle (Saale)

GERMANY

View details

Niklas Sturm

University Hospital Ulm

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sebastian Krug

Research Interests

Explore related searches

Contact this professor

Articles (10)

Diarrhea Associated With Sigmoid Cancer—As Usual?

Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience

The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease

Postoperative Sigmoidoscopy and Biopsy After Elective Endovascular and Open Aortic Surgery for Preventing Mortality by Colonic Ischemia (PSB-Aorta-CI): Protocol for a Prospective Study

Lumen-apposing metal stent gastrojejunostomy for biliary drainage of an obstructive biliodigestive anastomosis

Updates on Diagnostic and Therapeutic Management of Gastrointestinal and Pancreatic NET

The impact of atezolizumab and bevacizumab in hepatocellular carcinoma with activated ß‐catenin signaling

Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer—A Systematic Review and Meta-Analysis

Finding the Appropriate Therapeutic Strategy in Patients with Neuroendocrine Tumors of the Pancreas: Guideline Recommendations Meet the Clinical Reality

Targeting HDACs in Pancreatic Neuroendocrine Tumor Models

Collaborators (9)

Marko Damm

Ulrich Ronellenfitsch

Florian van Bömmel

Jörg Kleeff

Jens Walldorf

Maria A. Gonzalez‐Carmona

Marino Venerito

Jörg Ukkat

Niklas Sturm

Make your next move.